万维提示：
1、投稿方式：在线投稿。
2、刊内网址：http://www.jgenetgenomics.org
http://www.elsevier.com/locate/jgg
自动跳转至：
https://www.journals.elsevier.com/journal-of-genetics-and-genomics
3、投稿系统：https://www.editorialmanager.com/jgg
4、出刊日期：月刊，每月20日出版。
2022年9月1日星期四
《遗传学报（英文版）》作者指南Guid for authors
【官网信息】
AIMS AND SCOPE
The Journal of Genetics and Genomics (JGG, formerly known as Acta Genetica Sinica) is an international journal publishing peer-reviewed articles of novel and significant discoveries in the fields of genetics and genomics. Topics of particular interest include but are not limited to molecular genetics, developmental genetics, cytogenetics, epigenetics, medical genetics, population and evolutionary genetics, genomics and functional genomics as well as bioinformatics and computational biology.
The main article types include original research, review, method article, letter to the editor, resource, highlight, and meeting report. Currently, JGG is indexed by Science Citation Index Expanded (SCI-E), Medline, Scopus, Biosis Previews and Chemical Abstracts. JGG publishes papers in English only and is distributed internationally.
Types of article
Original Research The original research article including method article should be organized in the following order: Title page, Abstract, Introduction, Results, Discussion, Materials and methods, Acknowledgements, References, Tables, and Figure legends. Figures and regular Supplementary data should be uploaded as separate files and not as part of the manuscript. These files will be converted, along with the manuscript, into a single PDF on upload.
Review The review article should be focused on topics of interest to broad readership. It should be organized in the following order: Title Page, Abstract, Introduction, Text with labelled topics and subtopics, Concluding remarks (Perspectives), Acknowledgements, References, Tables, and Figure legends. Figures should be separately uploaded and not enclosed in the text. The length is usually not less than 5000 words.
Letter to the Editor Letter to the Editor is a brief report on novel findings without sufficient depth to qualify as an original research article. There is no abstract, and only one composite figure and/or table reflecting the main results is included. The additional results and important materials and methods should be showed as Supplementary Data. The length of main text (excluding the references) is limited to less than 2000 words, and the total number of the references is limited to 20. The author's name(s) and affiliation(s) should be put at the end of the text.
Ethics in publishing
Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.
Studies in humans and animals
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.
Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study.
Declaration of interest
The Journal of Genetics and Genomics follows the ICMJE recommendations regarding conflict of interest disclosures. All authors are required to report the following information with each submission: (1) All third-party financial support for the work in the submitted manuscript. (2) All financial relationships with any entities that could be viewed as relevant to the general area of the submitted manuscript. (3) All sources of revenue with relevance to the submitted work who made payments to you, or to your institution on your behalf, in the 36 months prior to submission. (4) Any other interactions with the sponsor of outside of the submitted work should also be reported. (5) Any relevant patents or copyrights (planned, pending, or issued). (6) Any other relationships or affiliations that may be perceived by readers to have influenced, or give the appearance of potentially influencing, what you wrote in the submitted work. As a general guideline, it is usually better to disclose a relationship than not. This information will be acknowledged at publication in a Transparency Document link directly in the article. Additional information on the ICMJE recommendations can be found at: http://www.icmje.org/. The form for conflict of interest disclosure can be downloaded here: http://www.icmje.org/coi_disclosure.pdf (if this link does not display properly in your browser, please right-click the link and select "Save Target As..." or "Save Link as..." from the pop-up menu).
Submission declaration
Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder.
Use of inclusive language
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.
Author contributions
For transparency, we encourage authors to submit an author statement file outlining their individual contributions to the paper using the relevant CRediT roles: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Roles/Writing - original draft; Writing - review & editing. Authorship statements should be formatted with the names of authors first and CRediT role(s) following. More details and an example
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases. For open access articles: Upon acceptance of an article, authors will be asked to complete an 'Exclusive License Agreement' (more information). Permitted third party reuse of open access articles is determined by the author's choice of user license.
……
更多详情：
http://www.jgenetgenomics.org/news/gfa.htm
